Waratah Capital Advisors Ltd. Dexcom Inc Transaction History

Waratah Capital Advisors Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $1.94 Million - $2.47 Million	17,570 Added 33.42%	70,149 $7.95 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $6.17 Million - $7.57 Million	-54,049 Reduced 50.69%	52,579 $7.29 Million
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $3.34 Million - $5.49 Million	44,221 Added 70.86%	106,628 $13.2 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $2.21 Million - $3.55 Million	-25,709 Reduced 29.18%	62,407 $5.82 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $1.35 Million - $1.57 Million	-12,021 Reduced 12.0%	88,116 $11.3 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $7.88 Million - $9.31 Million	75,734 Added 310.35%	100,137 $11.6 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $2.07 Million - $2.99 Million	24,403 New	24,403 $2.76 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $125,373 - $245,049	-1,844 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$94.08 - $130.2 $173,483 - $240,088	1,844 New	1,844 $943,000
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $372,462 - $582,696	-10,171 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$35.53 - $43.8 $361,375 - $445,489	10,171 New	10,171 $1.52 Million

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Waratah Capital Advisors Ltd., based on Form 13F filings with the SEC.

Stay updated on Waratah Capital Advisors Ltd. with notifications on news.